ROSSARI BIOTECH LIMITED
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it offers poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 1997 and is based in Mumbai, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Revenue grew 19.0% YoY
Concerns1
- Negative free cash flow (βΉ10 Cr)
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ1.43 K Cr | β | βΉ115.00 Cr | β | β | 10.7% | 19.0% | 15.0% |
| Mar 2024 | βΉ1.20 K Cr | β | βΉ100.00 Cr | β | β | 10.4% | 23.4% | 40.8% |
| Mar 2023 | βΉ975.00 Cr | β | βΉ71.00 Cr | β | β | 8.3% | -9.1% | -10.1% |
| Mar 2022 | βΉ1.07 K Cr | β | βΉ79.00 Cr | β | β | 10.1% | 55.5% | 0.0% |
| Mar 2021 | βΉ690.00 Cr | β | βΉ79.00 Cr | β | β | 19.6% | 15.0% | 19.7% |
| Mar 2020 | βΉ600.00 Cr | β | βΉ66.00 Cr | β | β | 23.3% | 16.3% | 43.5% |
| Mar 2019 | βΉ516.00 Cr | β | βΉ46.00 Cr | β | β | 38.3% | 76.7% | 58.6% |
| Mar 2018 | βΉ292.00 Cr | β | βΉ29.00 Cr | β | β | 32.6% | 25.3% | 81.3% |
| Mar 2017 | βΉ233.00 Cr | β | βΉ16.00 Cr | β | β | 26.7% | 30.9% | 433.3% |
| Mar 2016 | βΉ178.00 Cr | β | βΉ3.00 Cr | β | β | 6.7% | 45.9% | -40.0% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 1,580 |
| Total Expenses | 1,384 |
| EBIT / Operating Profit | 197 |
| OPM % | 12% |
| Other Income | 7 |
| Finance Costs | 11 |
| Depreciation & Amortisation | 30 |
| Profit Before Tax | 163 |
| Tax % | - |
| Net Profit / PAT | 120 |
| EPS (βΉ) | 21.75 |
| Dividend Payout % | - |
Peer Comparison
Technology sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| ROSSARI BIOTECH LIMITEDthis co. | βΉ3.02 K Cr | βΉ1.43 K Cr | 25.00 | 2.67 | 17.69 | 19.0% |
| Bharti Airtel Ltd. | βΉ12.19 L Cr | βΉ1.09 L Cr | 50.40 | 8.31 | 27.19 | 15.8% |
| Tata Consultancy Services Ltd. | βΉ11.84 L Cr | βΉ2.15 L Cr | 24.20 | 13.91 | 18.91 | 6.2% |
| Infosys Ltd | βΉ6.48 L Cr | βΉ1.37 L Cr | 24.20 | 7.17 | 16.31 | 5.9% |
| HCL Technologies Ltd | βΉ4.52 L Cr | βΉ51.10 K Cr | 36.80 | 14.48 | β | 6.2% |
| Bharat Electronics Ltd. | βΉ3.02 L Cr | βΉ23.66 K Cr | 53.30 | 14.23 | 51.32 | 17.3% |
| Wipro Ltd. | βΉ2.77 L Cr | βΉ67.29 K Cr | 23.00 | 4.29 | 18.85 | 0.8% |
| Industry Average | β | βΉ10.05 K Cr | 69.99 | 8.58 | 66.75 | 22.0% |